1. Home
  2. PGEN vs OPRA Comparison

PGEN vs OPRA Comparison

Compare PGEN & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.81

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$18.38

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
OPRA
Founded
1998
1996
Country
United States
Norway
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
PGEN
OPRA
Price
$3.81
$18.38
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.33
$21.50
AVG Volume (30 Days)
4.0M
340.3K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
4.61%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$21.29
Revenue Next Year
$81.04
$15.34
P/E Ratio
N/A
$13.62
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$11.71
52 Week High
$5.47
$21.06

Technical Indicators

Market Signals
Indicator
PGEN
OPRA
Relative Strength Index (RSI) 38.10 54.05
Support Level $3.49 $13.08
Resistance Level $4.40 $19.24
Average True Range (ATR) 0.29 0.60
MACD -0.07 0.01
Stochastic Oscillator 2.97 56.98

Price Performance

Historical Comparison
PGEN
OPRA

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About OPRA Opera Limited

Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.

Share on Social Networks: